SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-063344
Filing Date
2022-03-03
Accepted
2022-03-02 21:03:02
Documents
6
Effectiveness Date
2022-03-03

Document Format Files

Seq Description Document Type Size
1 POSASR d296560dposasr.htm POSASR 326093
2 EX-5.1 d296560dex51.htm EX-5.1 18244
3 EX-23.1 d296560dex231.htm EX-23.1 1802
4 EX-FILING FEES d296560dexfilingfees.htm EX-FILING FEES 91860
5 GRAPHIC g296560g08j64.jpg GRAPHIC 45914
6 GRAPHIC g296560g23z30.jpg GRAPHIC 10067
  Complete submission text file 0001193125-22-063344.txt   512458
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-260754 | Film No.: 22706436
SIC: 2834 Pharmaceutical Preparations